These data, along with evidence from ovarian and lung cancers linking high S1P levels to metastatic spread [16,17,18,19] and poor prognosis [20,21], further highlight the therapeutic potential of S1P axis inhibition in OS. The gene discussed is MBTPS1; the disease is lung carcinoma.